HAHN MATHEW A 4
4 · ACCELRYS, INC. · Filed Mar 18, 2013
Insider Transaction Report
Form 4
ACCELRYS, INC.ACCL
HAHN MATHEW A
VP, Research and Development
Transactions
- Sale
Common stock
2013-03-15$9.69/sh−50,000$484,310→ 0 total
Footnotes (1)
- [F1]Disposition of common stock acquired through sale of Scitegic to Accelrs in 2004.